PIK3CA, ESR1 and TP53 were the most affected genes, comparable with other studies that have used the InVision [36], Oncomine Breast Cancer [26], and PredicinePLUSTM [13] panels for hormone receptor-positive mBC. This evidence concerns the gene NR4A1 and breast cancer.